Cost-effectiveness of preventing hip fractures by hip protectors in elderly institutionalized residents in Germany

Value in Health

Volumn 11, Issue 7, 2008, Pages 1088-1095

  Gandjour, Afschin ^a   Weyler, Eva Julia ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cost effectiveness; Hip fractures; Hip protectors; Markov model

Indexed keywords

AGING; ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVICE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HIP FRACTURE; HOSPITAL MANAGEMENT; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

EID: 53749085232     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00393.x     Document Type: Article

References (44)

1. Cummings S. Nursing home residence and risk of hip fracture. Am J Epidemiol 1996 143 : 1191 4.
2. Bundergerchäftrrtelle Qualitätrricherung. BQS- Qualitätsreport, 2004. Available from: http://www.bqs-qualitaetsreport.de/ 2004/ergebnisse/leistungsbereiche/hueftgelenknahe_femurfraktur/ [Accessed October 11, 2005 A, Weyler EJ. Socioeconomic burden of hip fractures in Germany. Gesundheitswesen 2007 69 : 601 6.
3. Chapuy M, Arlot M, Delmas P, et al. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994 308 : 1081 2.
4. Gillespie LD, Gillespie WJ, Robertson MC, et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003 CD000340.
5. Kannus P, Sievanen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005 366 : 1885 93.
6. Papapoulos S, Sara A, Quandt U, et al. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int 2005 16 : 468 74.
7. Parker M, Gillespie L, Gillespie W. Hip protectors for preventing hip fractures in the elderly (Cochrane Review). The Cochrane Library, Issue 1, Update Software, Oxford, 2005.
8. Cumming RG, Klineberg RJ. Case-control study of risk factors for hip fractures in the elderly. Am J Epidemiol 1994 139 : 493 503.
9. Brennan J, Johansen A, Butler J, et al. Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporos Int 2003 14 : 515 9.
10. Bundesministerium für Familie, Senioren, Frauen und Jugend (BMFSFJ). Dritter Bericht zur Lage der älteren Generation. BMFSFJ 2001 und Vierter Bericht zur Lage der älteren Generation. Berlin : BMFSFJ, 2002.
11. Singh S, Sun H, Anis A. Cost-Effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol 2004 31 : 1607 13.
12. Waldegger L, Cranney M, Hing MS, Coyle D. Cost-effectiveness of hip protectors in institutional dwelling elderly. Osteoporos Int 2003 14 : 243 50.
13. Segui-Gomez M, Keuffel E, Frick KD. Cost and effectiveness of hip protectors among the elderly. Int J Technol Assess Health Care 2002 18 : 55 66.
14. Colon-Emeric C, Datta S, Matchar D. An economic analysis of external hip protector use in ambulatory nursing facility residents. Age Ageing 2003 32 : 47 52.
15. Honkanen LA, Schackman BR, Mushlin AI, Lachs MS. A cost-benefit analysis of external hip protectors in the nursing home setting. J Am Geriatr Soc 2005 53 : 190 7.
16. Sawka AM, Gafni A, Boulos P, et al. Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada. Osteoporos Int 2007 18 : 819 27.
17. Meyer G, Wegscheider K, Kersten JF, et al. Increased use of hip protectors in nursing homes: economic analysis of a cluster randomized, controlled trial. J Am Geriatr Soc 2005 53 : 2153 8.
18. Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ 2006 15 : 677 87.
19. Gandjour A, Weyler EJ. Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries. Health Care Manage Sci 2006 9 : 359 69.
20. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993 13 : 322 38.
21. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
22. Agency for healthcare research and quality. http://www.ahrq.gov/ [Accessed December 29, 2005 Bericht : Pflegestatistik, 2001. Pflege im Rahmen der Pflegeversicherung - Pflegebedürftige. Statistisches Bundesamt, Zweigstelle Bonn, 2003.
23. Siebert U. Transparente Entscheidungen in Public Health mittels systematischer Entscheidungsanalyse. In : Schwartz FW, Badura B, Busse R, Leidl R, Raspe H, Siegrist J, Walter U, eds, Das Public Health Buch. München, Jena : Urban & Fischer, 2003.
24. Statistisches Bundesamt, Sterbetafel 2002/2004. Available from: http://www.destatis.de/download/d/bevoe/sterbet04.xls [Accessed October 17, 2005 E, Tate R. Survival patterns of nursing home admissions and their policy implications. Can J Public Health 1988 79 : 268 74.
25. Meyer G, Warnke A, Bender R, Mühlhauser I. Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial. BMJ 2003 326 : 76.
26. Hoffmann F, Glaeske G. Inzidenz proximaler Femurfrakturen in Deutschland. Personenbezogene Analyse einer Versichertenpopulation. Gesundheitswesen 2006 68 : 161 4.
27. Parker M, Gillespie L, Gillespie W. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 2006 332 : 571 4.
28. Bayrische Arbeitsgemeinschaft für Qualitätssicherung in der stationären Versorgung (BAQ). Gesamtstatistik hüftgelenksnaher Femurfrakturen. Jahresauswertung 2004, Modul 17/1. München : Geschäftsstelle BAQ, 2004.
29. Schürch M, Rizzoli R, Mermillod H, et al. A Prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 1996 11 : 935 42.
30. Pientka L, Friedrich C. Die Kosten hüftgelenksnaher Frakturen in Deutschland: Eine prospective Untersuchung. Z Gerontol Geriat 1999 32 : 326 32.
31. van Schoor N, Deville W, Bouter LM, Lips P. Acceptance and compliance with external hip protectors: a systematic review of the literature. Osteoporos Inter 2002 13 : 917 24.
32. Münster U. Medizincontrolling der DRG Research Group 2006. http://drg.uni-muenster.de/de/webgroup/m.webgroup.php?menu=6 [Accessed October 22, 2005 RT, Schurmann N. Cost analysis of hip and knee prostheses as the basis for cost benefit evaluation. Zentralbl Chir 2001 126 : 55 61.
33. Krauth C, Hessel F, Hansmeier T, et al. Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005 67 : 736 46.
34. Bundesregierung, Leistungskatalog der Pflegeversicherung. Available from: http://www.bundesregierung.de/Artikel-,413.708498/leistungskatalog-der- pflegever.htm [Accessed April 21, 2005 J, Zethraeus N, Svensson O, et al. Femoral neck fractures in the elderly: functional outcome and quality of life according to EuroQol. Qual Life Res 2002 11 : 473 81.
35. Blomfeldt R, Törnkvist H, Ponzer S, et al. Internal fixation versus hemiarthroplasty for displaced fractures of the femoral neck in elderly patients with severe cognitive impairment. J Bone Joint Surg [Br 2005 87 B : 523 9.
36. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making 2003 23 : 341 50.
37. Stinnet AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998 18 : 68 80.
38. Sawka AM, Boulos P, Beattie K, et al. Do hip protectors decrease the risk of hip fracture in institutional- and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2005 16 : 1461 74.
39. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 1996 5 : 141 54.
40. Schousboe JT, Ensrud KE, Nyman JA, et al. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 2005 53 : 1697 704.
41. Mobley LR, Hoerger TJ, Wittenborn JS, et al. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate. Med Decis Making 2006 26 : 194 206.
42. Müller D, Weyler EJ, Gandjour A. Cost-effectiveness of postmenopausal osteoporosis screening and treatment based on ten-year fracture risk. Pharmacoeconomics In press.
43. Haussler B, Gothe H, Gol D, et al. Epidemiology, treatment and costs of osteoporosis in Germany - the BoneEVA Study. Osteoporos Int 2007 18 : 77 84.
44. Gandjour A, Lauterbach KW. Does prevention save costs? Considering deferral of the expensive last year of life. J Health Econ 2005 24 : 715 24.